World leading GMP manufacturing of mRNA and Cell & Gene Therapies

Our in-house GMP manufacturing unit of mRNA and Cell & Gene Therapies also offers third party services.

Founded in 1997, EUFETS GmbH specializes in services for innovative therapeutic approaches. In 2009, EUFETS became a 100% subsidiary of BioNTech AG, endowing BioNTech with synergistic platforms and complementary expertise for development, testing and manufacturing services.

Please visit the EUFETS website for more information.